Bioengineered Stents Market Forecast and Scope - 2031
The Bioengineered Stents Market is expected to register a CAGR of 8.3% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented By Application (Coronary Artery Disease, Peripheral Arterial Disease, Carotid Artery Disease, Renal Artery Stenosis, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm and others); Product (Drug-eluting Stents, Bio absorbable Stents and Drug-Eluting Balloons); Mode of Delivery (Balloon-expandable stents and Self-expanding stents); Material (Metal-based and Polymer-based); End User (Hospitals cardiac centers, Ambulatory Surgical Centers and others). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Bioengineered Stents Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Bioengineered Stents Market Segmentation
Application- Coronary Artery Disease
- Peripheral Arterial Disease
- Carotid Artery Disease
- Renal Artery Stenosis
- Abdominal Aortic Aneurysm
- Thoracic Aortic Aneurysm and others
- Drug-eluting Stents
- Bio absorbable Stents and Drug-Eluting Balloons
- Balloon-expandable stents and Self-expanding stents
- Metal-based and Polymer-based
- Metal-based and Polymer-based
Strategic Insights
Bioengineered Stents Market Growth Drivers- Rising Incidence of Cardiovascular Diseases: Growing incidence of cardiovascular diseases involving sedentary lifestyles, lack of proper dietary habits, and increasing levels of obesity are demanding an increase in the use of bioengineered stents. Increasing demand for better treatment options from providers is going to result in more of this market for innovative stent technologies that are going to help in offering better healing and reducing complications.
- Rising Awareness and Screening: This surging awareness of cardiovascular diseases and advancements in medical technology has increased the demand for preventive care. Preventive care has become one amongst the priorities, which makes the screening practice more rigorous apart from carrying intervention before the progression of disease. Conscientious patients are on the lookout for treatments with fewer complications concerning heart procedures and better results. This will make patients use bioengineered stents.
- Regulatory and Cost Considerations: Regulatory clearance and cost-effectiveness are critical forces in the bioengineered stent market. Although regulations ensure safety and efficacy, they also delay the time-to-market of new products; with healthcare systems shifting to value-based care, manufacturers will be challenged to prove long-term benefits and cost-effectiveness concerning obtaining favorable reimbursement policies and access to the marketplace.
- Aging Population: Gastrointestinal disorders are more likely to be associated with geriatric population. This increases the demand for diagnostic and therapeutic procedures. Older people are also more vulnerable to many gastrointestinal conditions, thereby reflecting the necessity for reliable diagnostic and therapeutic equipment such as bioengineered stents.
- Technological Advancements: The market for bioengineered stents remains under the influence of continuous technological advancements. There is a promise of targeted therapy with the minimum of complications in the long run by drug-eluting and bioresorbable stents. This accelerates patient recovery, reducing the frequency of repeat interventions while promoting demand and preference among cardiologists and patients alike for these advanced solutions.
- R&D and Clinical Trials: The biodegradable polymers and drug-eluting technologies have drawn a lot of R&D effort into the development of innovative materials in the bioengineered stents market, with a vision of better outcomes for the patients. Clinical trials fundamentally focus on the major areas of enhanced biocompatibility, lower restenosis rates, and personalized medicine approaches. Amongst these, the trend towards less-invasive procedures and real-time monitoring is expected to fuel this market growth and continuously enhance medical applications in cardiovascular and other niche areas..
- Biodegradable Stents: The market for biodegradable stents is exploding at a rapid pace with innovative products in bioengineering material science that enhance tissue integration and minimize long-term complications, including new polymers, enhanced drug-eluting technologies, and patient-specific designs. Growing regulatory approvals of the same and growing awareness among healthcare providers are further impelling the growth and adoption of the market.
- Collaboration and Partnerships: Bioengineered stents have lately seen tremendous collaboration between the medical device companies and the firms, particularly the biotechnology, oriented towards new materials and drug-eluting technologies. Collaboration with research institutions for improvement of biocompatibility and the reduction of complications is also taking place. The level of cooperation for regulatory approval and clinical trials is also increasing, leading to improved design of stent systems and expanding access to markets and, thereby, patients' benefit.
- Untapped opportunities from Emerging Economies: The emerging economies of the world, bioengineered stent market expansion opportunities are still untapped with improved healthcare infrastructure remaining on a continuously upward trajectory in Asia- Pacific and Latin America. More investment in healthcare services coupled with increasing awareness of cardiovascular health create fertile grounds for growth. Companies entering this market with affordable and innovative stent solutions have the promise of growing much further as it could address both demand and access issues.
- Investment in Healthcare Infrastructure: Improved cardiovascular care will arise from new investments in health care infrastructures. Investments targeted at upgrading production, research, and distribution networks would spur innovation as well as lead to improved patient outcomes and access in a very instrumental way. The inclusion of these agencies and health care providers will further streamline the process for efficient deployment of advanced technologies for stents to diverse patient populations.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Bioengineered Stents Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Bioengineered Stents Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
The market is expected to grow at a CAGR of 8.3%
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
The North America region accounts for highest revenue share bioengineered stents market
Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys SA, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W.L. Gore and Associatesare the some of the key market players operating in the bioengineered stents market
increasing prevelance of cradiovascular disorders and surging awareness and screening for cradiovascular diosrders are the major factors boosting the bioengineered stents market growth
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Bioengineered Stents Market - By Application
1.3.2 Bioengineered Stents Market - By Product
1.3.3 Bioengineered Stents Market - By Mode of Delivery
1.3.4 Bioengineered Stents Market - By Material
1.3.5 Bioengineered Stents Market - By End User
1.3.6 Bioengineered Stents Market - By Region
1.3.6.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. BIOENGINEERED STENTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. BIOENGINEERED STENTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. BIOENGINEERED STENTS MARKET - GLOBAL MARKET ANALYSIS
6.1. BIOENGINEERED STENTS - GLOBAL MARKET OVERVIEW
6.2. BIOENGINEERED STENTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET FORECASTS AND ANALYSIS
7.3. CORONARY ARTERY DISEASE
7.3.1. Overview
7.3.2. Coronary Artery Disease Market Forecast and Analysis
7.4. PERIPHERAL ARTERIAL DISEASE
7.4.1. Overview
7.4.2. Peripheral Arterial Disease Market Forecast and Analysis
7.5. CAROTID ARTERY DISEASE
7.5.1. Overview
7.5.2. Carotid Artery Disease Market Forecast and Analysis
7.6. RENAL ARTERY STENOSIS
7.6.1. Overview
7.6.2. Renal Artery Stenosis Market Forecast and Analysis
7.7. ABDOMINAL AORTIC ANEURYSM
7.7.1. Overview
7.7.2. Abdominal Aortic Aneurysm Market Forecast and Analysis
7.8. THORACIC AORTIC ANEURYSM AND OTHERS
7.8.1. Overview
7.8.2. Thoracic Aortic Aneurysm and others Market Forecast and Analysis
8. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. DRUG-ELUTING STENTS
8.3.1. Overview
8.3.2. Drug-eluting Stents Market Forecast and Analysis
8.4. BIO ABSORBABLE STENTS AND DRUG-ELUTING BALLOONS
8.4.1. Overview
8.4.2. Bio absorbable Stents and Drug-Eluting Balloons Market Forecast and Analysis
9. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2028 - MODE OF DELIVERY
9.1. OVERVIEW
9.2. MODE OF DELIVERY MARKET FORECASTS AND ANALYSIS
9.3. BALLOON-EXPANDABLE STENTS AND SELF-EXPANDING STENTS
9.3.1. Overview
9.3.2. Balloon-expandable stents and Self-expanding stents Market Forecast and Analysis
10. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2028 - MATERIAL
10.1. OVERVIEW
10.2. MATERIAL MARKET FORECASTS AND ANALYSIS
10.3. METAL-BASED AND POLYMER-BASED
10.3.1. Overview
10.3.2. Metal-based and Polymer-based Market Forecast and Analysis
11. BIOENGINEERED STENTS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. HOSPITALS CARDIAC CENTERS
11.3.1. Overview
11.3.2. Hospitals cardiac centers Market Forecast and Analysis
11.4. AMBULATORY SURGICAL CENTERS AND OTHERS.
11.4.1. Overview
11.4.2. Ambulatory Surgical Centers and others. Market Forecast and Analysis
12. BIOENGINEERED STENTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Bioengineered Stents Market Overview
12.1.2 North America Bioengineered Stents Market Forecasts and Analysis
12.1.3 North America Bioengineered Stents Market Forecasts and Analysis - By Application
12.1.4 North America Bioengineered Stents Market Forecasts and Analysis - By Product
12.1.5 North America Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.1.6 North America Bioengineered Stents Market Forecasts and Analysis - By Material
12.1.7 North America Bioengineered Stents Market Forecasts and Analysis - By End User
12.1.8 North America Bioengineered Stents Market Forecasts and Analysis - By Countries
12.1.8.1 United States Bioengineered Stents Market
12.1.8.1.1 United States Bioengineered Stents Market by Application
12.1.8.1.2 United States Bioengineered Stents Market by Product
12.1.8.1.3 United States Bioengineered Stents Market by Mode of Delivery
12.1.8.1.4 United States Bioengineered Stents Market by Material
12.1.8.1.5 United States Bioengineered Stents Market by End User
12.1.8.2 Canada Bioengineered Stents Market
12.1.8.2.1 Canada Bioengineered Stents Market by Application
12.1.8.2.2 Canada Bioengineered Stents Market by Product
12.1.8.2.3 Canada Bioengineered Stents Market by Mode of Delivery
12.1.8.2.4 Canada Bioengineered Stents Market by Material
12.1.8.2.5 Canada Bioengineered Stents Market by End User
12.1.8.3 Mexico Bioengineered Stents Market
12.1.8.3.1 Mexico Bioengineered Stents Market by Application
12.1.8.3.2 Mexico Bioengineered Stents Market by Product
12.1.8.3.3 Mexico Bioengineered Stents Market by Mode of Delivery
12.1.8.3.4 Mexico Bioengineered Stents Market by Material
12.1.8.3.5 Mexico Bioengineered Stents Market by End User
12.1.8.4 US Bioengineered Stents Market
12.1.8.4.1 US Bioengineered Stents Market by Application
12.1.8.4.2 US Bioengineered Stents Market by Product
12.1.8.4.3 US Bioengineered Stents Market by Mode of Delivery
12.1.8.4.4 US Bioengineered Stents Market by Material
12.1.8.4.5 US Bioengineered Stents Market by End User
12.2. EUROPE
12.2.1 Europe Bioengineered Stents Market Overview
12.2.2 Europe Bioengineered Stents Market Forecasts and Analysis
12.2.3 Europe Bioengineered Stents Market Forecasts and Analysis - By Application
12.2.4 Europe Bioengineered Stents Market Forecasts and Analysis - By Product
12.2.5 Europe Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.2.6 Europe Bioengineered Stents Market Forecasts and Analysis - By Material
12.2.7 Europe Bioengineered Stents Market Forecasts and Analysis - By End User
12.2.8 Europe Bioengineered Stents Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Bioengineered Stents Market
12.2.8.1.1 Germany Bioengineered Stents Market by Application
12.2.8.1.2 Germany Bioengineered Stents Market by Product
12.2.8.1.3 Germany Bioengineered Stents Market by Mode of Delivery
12.2.8.1.4 Germany Bioengineered Stents Market by Material
12.2.8.1.5 Germany Bioengineered Stents Market by End User
12.2.8.2 France Bioengineered Stents Market
12.2.8.2.1 France Bioengineered Stents Market by Application
12.2.8.2.2 France Bioengineered Stents Market by Product
12.2.8.2.3 France Bioengineered Stents Market by Mode of Delivery
12.2.8.2.4 France Bioengineered Stents Market by Material
12.2.8.2.5 France Bioengineered Stents Market by End User
12.2.8.3 Italy Bioengineered Stents Market
12.2.8.3.1 Italy Bioengineered Stents Market by Application
12.2.8.3.2 Italy Bioengineered Stents Market by Product
12.2.8.3.3 Italy Bioengineered Stents Market by Mode of Delivery
12.2.8.3.4 Italy Bioengineered Stents Market by Material
12.2.8.3.5 Italy Bioengineered Stents Market by End User
12.2.8.4 Spain Bioengineered Stents Market
12.2.8.4.1 Spain Bioengineered Stents Market by Application
12.2.8.4.2 Spain Bioengineered Stents Market by Product
12.2.8.4.3 Spain Bioengineered Stents Market by Mode of Delivery
12.2.8.4.4 Spain Bioengineered Stents Market by Material
12.2.8.4.5 Spain Bioengineered Stents Market by End User
12.2.8.5 United Kingdom Bioengineered Stents Market
12.2.8.5.1 United Kingdom Bioengineered Stents Market by Application
12.2.8.5.2 United Kingdom Bioengineered Stents Market by Product
12.2.8.5.3 United Kingdom Bioengineered Stents Market by Mode of Delivery
12.2.8.5.4 United Kingdom Bioengineered Stents Market by Material
12.2.8.5.5 United Kingdom Bioengineered Stents Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Bioengineered Stents Market Overview
12.3.2 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis
12.3.3 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Application
12.3.4 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Product
12.3.5 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.3.6 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Material
12.3.7 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Bioengineered Stents Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Bioengineered Stents Market
12.3.8.1.1 Australia Bioengineered Stents Market by Application
12.3.8.1.2 Australia Bioengineered Stents Market by Product
12.3.8.1.3 Australia Bioengineered Stents Market by Mode of Delivery
12.3.8.1.4 Australia Bioengineered Stents Market by Material
12.3.8.1.5 Australia Bioengineered Stents Market by End User
12.3.8.2 China Bioengineered Stents Market
12.3.8.2.1 China Bioengineered Stents Market by Application
12.3.8.2.2 China Bioengineered Stents Market by Product
12.3.8.2.3 China Bioengineered Stents Market by Mode of Delivery
12.3.8.2.4 China Bioengineered Stents Market by Material
12.3.8.2.5 China Bioengineered Stents Market by End User
12.3.8.3 India Bioengineered Stents Market
12.3.8.3.1 India Bioengineered Stents Market by Application
12.3.8.3.2 India Bioengineered Stents Market by Product
12.3.8.3.3 India Bioengineered Stents Market by Mode of Delivery
12.3.8.3.4 India Bioengineered Stents Market by Material
12.3.8.3.5 India Bioengineered Stents Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Bioengineered Stents Market Overview
12.4.2 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis
12.4.3 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Application
12.4.4 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Product
12.4.5 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.4.6 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Material
12.4.7 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Bioengineered Stents Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Bioengineered Stents Market
12.4.8.1.1 South Africa Bioengineered Stents Market by Application
12.4.8.1.2 South Africa Bioengineered Stents Market by Product
12.4.8.1.3 South Africa Bioengineered Stents Market by Mode of Delivery
12.4.8.1.4 South Africa Bioengineered Stents Market by Material
12.4.8.1.5 South Africa Bioengineered Stents Market by End User
12.4.8.2 Saudi Arabia Bioengineered Stents Market
12.4.8.2.1 Saudi Arabia Bioengineered Stents Market by Application
12.4.8.2.2 Saudi Arabia Bioengineered Stents Market by Product
12.4.8.2.3 Saudi Arabia Bioengineered Stents Market by Mode of Delivery
12.4.8.2.4 Saudi Arabia Bioengineered Stents Market by Material
12.4.8.2.5 Saudi Arabia Bioengineered Stents Market by End User
12.4.8.3 U.A.E Bioengineered Stents Market
12.4.8.3.1 U.A.E Bioengineered Stents Market by Application
12.4.8.3.2 U.A.E Bioengineered Stents Market by Product
12.4.8.3.3 U.A.E Bioengineered Stents Market by Mode of Delivery
12.4.8.3.4 U.A.E Bioengineered Stents Market by Material
12.4.8.3.5 U.A.E Bioengineered Stents Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Bioengineered Stents Market Overview
12.5.2 South and Central America Bioengineered Stents Market Forecasts and Analysis
12.5.3 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Application
12.5.4 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Product
12.5.5 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Mode of Delivery
12.5.6 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Material
12.5.7 South and Central America Bioengineered Stents Market Forecasts and Analysis - By End User
12.5.8 South and Central America Bioengineered Stents Market Forecasts and Analysis - By Countries
12.5.8.1 Argentina Bioengineered Stents Market
12.5.8.1.1 Argentina Bioengineered Stents Market by Application
12.5.8.1.2 Argentina Bioengineered Stents Market by Product
12.5.8.1.3 Argentina Bioengineered Stents Market by Mode of Delivery
12.5.8.1.4 Argentina Bioengineered Stents Market by Material
12.5.8.1.5 Argentina Bioengineered Stents Market by End User
13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
14. BIOENGINEERED STENTS MARKET, KEY COMPANY PROFILES
14.1. BOSTON SCIENTIFIC CORPORATION
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. ABBOTT LABORATORIES
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. BIOTRONIK SE AND CO. KG
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. BRAUN MELSUNGEN AG
14.4.1. Key Facts
14.4.2. Businessscription
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. TERUMO CORPORATION
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MICROPORT SCIENTIFIC CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. STENTYS SA
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. MERIL LIFE SCIENCES PVT. LTD
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. VASCULAR CONCEPTS
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. L. GORE AND ASSOCIATES
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments
15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERM
The List of Companies
1. Boston Scientific Corporation
2. Abbott Laboratories
3. Biotronik SE & Co. KG
4. Braun Melsungen AG
5. Terumo Corporation
6. MicroPort Scientific Corporation
7. Stentys SA
8. Meril Life Sciences Pvt. Ltd
9. Vascular Concepts
10. L. Gore and Associates
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For